We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Targeting of Anti-hk2 Antibody in mCRPC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04116164
Recruitment Status : Unknown
Verified October 2020 by Tomopath Inc..
Recruitment status was:  Recruiting
First Posted : October 4, 2019
Last Update Posted : April 9, 2021
Sponsor:
Collaborators:
Invicro
Janssen Research & Development, LLC
Information provided by (Responsible Party):
Tomopath Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 30, 2021
Estimated Study Completion Date : December 31, 2021
Publications: